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Abstract  
Background. Left atrial appendage (LAA) is the major source of cardiac thrombi in 
atrial fibrillation (AF) and plays a major role in cardioembolic events.  
Objective. To investigate the correlation between LAA morphology and the burden of 
silent cerebral ischemia (SCI) as a new thromboembolic risk marker in AF patients. 
Methods: 348 AF patients undergoing trans-catheter ablation were enrolled. A cerebral 
MR was performed to assess SCI burden, while LAA morphology was studied by 
magnetic resonance (MR) or computed tomography (CT) and categorized as: Cactus in 
52 (14.9%) patients, ChickenWing in 177 (50.9%), WindSock in 101 (29.0%), and 
Cauliflower in 18 (5.2%).  
Results: SCIs were detected in 274 (84.8%) patients, with a median number of lesions of 
23. SCI burden related to LAA complexity: 30.8% and 17.3% patients with Cactus,  
30.5% and 22.0% with ChickenWing, 13.9% and 27.7% with Windsock, and 16.7% and 
38.9% with Cauliflower LAA were in the first and fourth quartile of number of SCI per 
patient, respectively (p=0.035). Following adjustment for potential confounders, only age 
(beta 0.12, 95% CI 0.08-0.16; p<0.001), ChickenWing (beta [-0.28], 95%CI [-0.51]-[-
0.04]; p=0.021), WindSock (beta 0.38, 95%CI 0.12-0.65; p=0.005) and Cauliflower (beta 
0.61, 95%CI 0.07-1.14; p=0.026) LAA morphologies significantly related to SCI burden.  
Conclusion. LAA morphology relates to the burden of SCI in AF patients. Future 
research should corroborate if accessible methods (e.g. echocardiography) are able to 
describe LAA morphology permitting its use within universal thromboembolic risk 
predictors in AF patients.  
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Introduction 
Independently from the presence of comorbidities AF relates to enhanced mortality and 
thromboembolism, particularly to the brain. In fact, patients with AF present an 
approximately five-fold higher risk of symptomatic cerebral events compared to the 
general population1.  
To predict the risk of thromboembolic events in AF patients a number of clinical scores 
have been evaluated2. However, the occurrence of an event, despite low risk score (e.g. 
CHA2DS2-VASc 0-1) unfortunately remains not unusual3,4. In this setting, the recently 
published data of a multicenter study showing a correlation between left atrial (LA) 
appendage (LAA) morphology and the risk of symptomatic stroke in patients with AF 
seems  promising5.  
In the attempt to ameliorate thromboembolic event prediction, the present study aims to 
relate the morphology of the LAA, one of the major sources of cardiac thrombus 
responsible for cerebral embolism in patients with AF, to the burden of silent cerebral 
ischemia (SCI)6,7,8.  
 
 
 
 
 
 
 
 
  7
Methods 
 
Study population 
In this multicenter retrospective study, 359 consecutive patients with AF referred for 
transcatheter ablation were enrolled from November 2008 to April 2010. For each patient 
cardiac magnetic resonance (MR) or computed tomography (CT) and cerebral MR were 
performed.   
Exclusion criteria have been elsewhere reported5. In addition eleven patients (3.1%) were 
excluded due to low quality of the CT/MR scans not permitting LAA visualization. 
All patients provided written informed consent and the study was conducted in 
accordance to the latest Declaration of Helsinki update. 
 
Baseline evaluation 
All subjects underwent extensive clinical assessment, including: medical history (targeted 
to presence of heart disease, comorbidities), thromboembolic risk assessment (CHA2DS2-
VASc score2), physical examination and 12-lead electrocardiogram.  
All patients underwent transthoracic and transesophageal echocardiography and the 
following parameters were measured9: left ventricle ejection fraction; LA antero-
posterior (A-P), medial-lateral (M-L) supero-inferior (S-I) diameters; and LAA outflow 
velocity.  
 
Imaging protocols 
Cardiac MR and CT imaging of the LA was performed as previously detailed5.  
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LAA morphology was categorized, based on previous literature10, in one of the four 
progressively more complex types: Cactus, a dominant central lobe with small chambers 
extending in all directions; ChickenWing, an obvious bend in the proximal or middle part 
of the dominant lobe; WindSock, a dominant lobe plus secondary or even tertiary lobes 
arising from the dominant lobe; and Cauliflower, complex internal characteristics with 
lack of a dominant lobe. The total number of lobes for each LAA morphology was also 
recorded11.  
Cerebral scans were performed as previously detailed12. According to anatomo-
pathological criteria13 SCI were defined as focal, sharply demarcated, regularly or 
irregularly shaped areas hyperintense on T2-FLAIR or isointense in T1 weighted image. 
Each individual SCI detected was registered, independently from size. 
All MR/CT scans were independently analyzed by two operators, blinded to clinical data; 
conflict was resolved by common agreement referring to a third expert.  
 
Statistical analysis 
Continuous variables, presented as means and standard deviations (SD), were compared 
by Student’s t-test or analysis of variance (ANOVA) after normal distribution was 
assured by Shapiro-Wilk test. Number of SCI, instead, was presented as median and 
quartiles and compared by Kruskal-Wallis test. Categorical variables, presented as counts 
and percentages, were compared by cross tabulation tables by Pearson's chi-square or 
Fisher’s exact tests, as appropriate. Interobserver agreement between readers (for each 
imaging modality) was evaluated by Cohen’s kappa for LAA morphology classification 
and by coefficient of reproducibility (Bland-Altman analysis based on average and 
  9
difference of both examiners (100*SD(difference)/mean(average)) for SCI detection. A 
linear regression multivariate model, adjusted for all parameters emerged as potential 
confounders at univariate analysis (p-value below 0.1) was run to assess if LAA 
morphology (considered as each LAA morphology against all others by insertion in the 
model of an individual “dummy variable” for each of the four morphologies) 
independently related to the number of SCI (regression coefficients [beta] and 95% 
confidence intervals [95%CI] reported).  
All analyses were performed by 18.0 SPSS package for Windows (SPSS Inc, Chicago, 
IL, USA) and a two-sided p-value below 0.05 was considered as statistically significant. 
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Results  
Baseline characteristics of the 348 patients enrolled are listed in Table 1.  
Cactus type LAA was found in 52 patients (14.9%), ChickenWing in 177 (50.9%);  
WindSock in 101 patients (29.0%) and Cauliflower in 18 (5.2%; Figure 1). No significant 
bias was noted in classifying LAA morphology by operators both using MR (Cohen’s 
kappa 0.81, 95%CI 0.75-0.87) than CT (Cohen’s kappa 0.84, 95%CI 0.61-0.96).  
At cerebral MR at least one SCI (Figure 2) was detected in 295 (84.8%) patients, with a 
median number of lesions in each patient of 23, inter quartiles (IQ) 6-43. Interobserver 
variability, expressed as coefficient of reproducibility assessed by Bland-Altman method, 
was 5.6% (from -3.8 to +4.0%; p<0.01). 
Table 2 illustrates LA and LAA echocardiographic and MR/CT measurements stratified 
by SCI burden. Out of these, LA A-P and S-I diameters (p=0.0035 and p=0.001, 
respectively) related to SCI distribution in the population. The total number of lobes in 
each LAA - one lobe in 38.7% patients, while 2 or more lobes in the remaining cases (2 
lobes, 42.6%; 3 lobes, 16,1%; 4 lobes, 2.3%; and 6 lobes, 0,3%) - instead, did not relate 
to SCI burden (p=0.698). 
Eventually, the median number of SCI significantly differed by LAA morphology 
(p=0.028);  the correlation between SCI quartiles and LAA type is illustrated in Figure 3. 
In fact, 30.8 and 17.3% patients with Cactus and 30.5 and 22.0% with ChickenWing, the 
simplest morphologies, compared to 13.9 and 27.7% with Windsock, and 16.7 and 38.9% 
with Cauliflower LAA,  the most complex LAAs, were in the first and fourth quartile of 
number of SCI per patient, respectively (p=0.035).  
To detect if LAA morphology relates to SCI burden independently from other clinical or 
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instrumental variables recorded and possibly involved, a multivariate model, adjusted for 
all parameters emerged as potential confounders at univariate analysis (p-value below 
0.1), was computed. By this analysis, only age (beta 0.12, 95% CI 0.08-0.16; p<0.001), 
ChickenWing (beta [-0.28], 95%CI [-0.51]-[-0.04]; p=0.021), WindSock (beta 0.38, 
95%CI 0.12-0.65; p=0.005) and Cauliflower (beta 0.61, 95%CI 0.07-1.14; p=0.026) 
LAA morphologies resulted as independently related to SCI burden (Table 3).  
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Discussion  
The main results of the present study are that age and LAA morphology independently 
relate to SCI burden in AF patients referred for transcatheter ablation. If the fact that 
advancing age is linked to an increasing risk of cerebrovascular events is well         
known14, the role of the LAA, although a recognized source of cardiac thrombi has not 
been sufficiently investigated.  
Based on previous literature LAA morphology has been standardized in four different 
types, characterized by increasing complexity (Cactus, ChickenWing, WindSock, 
Cauliflower)10. LAA type is to date easily recognized by commonly performed imaging 
techniques in patients referred for AF transcatheter ablation, as CT and MR.  
On the other side, evaluation of the thromboembolic risk was based on the presence of 
SCI, evaluated by cerebral MR. Silent ischemic cerebral damage potentially includes a 
broad spectrum of lesions determined by several ethio-pathological causes. In the last 
years, however, several Authors have analyzed in post mortem studies the relationship 
between MR findings and the neuro-pathological specimens aiming to optimize a SCI 
definition able to selectively describe the small cerebral hyperintensities, as those 
described in the present study and highlighted in Figure 2, most likely related to embolic 
causes13. In fact, the MR imaging protocol hereby performed allows to differentiate, by 
T2-FLAIR cerebral MR weighted sequences, AF related gliotic ischemic lesions 
(hyperintense on T2-FLAIR weighted sequences and isointense in T1 sequences) from 
other unspecific findings as perivascular spaces and lacunes (hypointense on T2-FLAIR 
weighted sequences)15,16.  
The sensitivity of this recently introduced MR technique is, therefore, the most plausible 
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cause of the high SCI prevalence reported. In fact, our data seem more in agreement with 
MR based studies reporting SCI in AF patients ranging from 75 to 86%17,18 compared to 
those based on cerebral CT scans ranging from 13% to 48%19,20.  
Thromboembolic events in AF patients are known to be due to endothelial dysfunction, 
abnormal blood stasis and hypercoagulable state (the Virchow’s triad)21,22 resulting in 
gliotic ischemic lesions. The silent lesions detected by cerebral MR, deriving from 
microembolization of multiple small platelet thrombi in the terminal brain vessels 
(especially the leptomeningeal arteries), therefore represent a quantifiable measure of the 
thromboemoblic risk of the patient. Not surprisingly SCI have widely proved to predict 
the subsequent risk of symptomatic strokes23,24. Although no strong evidence exists in 
favor of a prevention or reduction of SCI by antiaggregants/anticoagulation it is 
reasonable (and supported by small previous studies17,25) to suppose that these therapies 
may prevent events also in the early stages of the AF-related cerebral damage, including 
cognitive impairement6.  
The observation that different LAA morphologies relate to SCI burden may hence be 
explained assuming that a more complex internal anatomical structure, such as that of the 
WindSock and Cauliflower LAAs, more intensively promotes local blood stasis and 
thrombogenesis compared to a simpler structure, as the ChickenWing LAA. The 
correlation between LAA morphology and thromboembolic risk in patients with AF is an 
original topic. To the best of our knowledge the first time this relationship was 
investigated was in a multicenter study, performed by the same centers involved in the 
present study, reporting a protective odds ratio for symptomatic stroke and TIA in AF 
patients with ChickenWing, compared to other LAA morphologies5. The latter report, 
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although performed on a considerable number of patients (932), relied on the distribution 
of symptomatic cerebrovascular events, suffered by a small proportion of the population 
(8%). This, together with the low prevalence of the Cactus LAA (30% and 15%, 
respectively in these two experiences), are the most plausible reasons explaining the lack 
of a protective effect proved by the simplest LAA morphology itself. Given these 
limitations, in the attempt to strengthen previous findings, the present work assessed, in a 
population at lower risk, the correlation between LAA morphology and burden of SCI, a 
more prevalent incident within AF patients.  
Of note, in the present study, hypertension, contrary to other previous reports14, did not 
emerge as a predictor of SCI. The SCI definition and MR protocol, in fact, prevented 
from including perivascular lacunar lesions, closely related to the hypertension-related 
microvascular damage. In addition, the present is a relatively young population (mean 
age 57 years) hypothetically not yet suffering the typical detrimental effects of long-term 
hypertension.  
In the present population, no peri-procedural overt cerebrovascular accident was 
encountered. During a clinical follow-up of about three years, instead, overt 
cerebrovascular accidents occurred in two (0.6%) patients, both presenting a 
ChickenWing LAA (the most prevalent morphology). This low incidence of overt events, 
surely influenced by the high rate of conversion and maintenance of sinus rhythm 
following AF ablation and by the fact that the majority of the patients were kept on oral 
anticoagulants after the procedure, does not permit any statistical inference computation 
but surely inspires further studies on the subject. Future research should also corroborate 
if LAA morphology results reproducibly assessable by easily available imaging methods 
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(e.g. bi and/or three dimensional echocardiography), to consider if its routine evaluation 
could improve the traditional thrombembolic risk assessment, especially in “low risk” AF 
patients.  
 
Limitations 
The following limitations need to be pointed out. In our analysis we excluded patients 
with history of prior TIA and or stroke to avoid including individuals with an evident 
high thromboembolic risk; generalization of our results to these patients is therefore not 
plausible. Patients with LAA spontaneous echo contrast/thrombi (an exclusion criteria) 
did not undergo cardiac MR; correlation between LAA morphology and this finding is 
hence unknown. As in previous studies on this topic an accurate measurement of the 
effective period of anticoagulant or antiaggregant therapy during exposure to the 
arrhythmia is lacking. Any retrospective correlation between pharmacological treatment 
and cerebral MR findings is therefore avoided. The present study does not present a 
matched control group; comparisons between AF and non-AF matched controls have, 
however, previously been conducted clearly reporting that non-AF patients are less prone 
to SCI (e.g. SCI prevalence of 53.8% and mean number of lesions 11.8 ± 20.417). 
Eventually, heart rhythm at the moment of the MR/CT scans was not recorded: presence 
of AF/sinus rhythm could have therefore hypothetically influenced quantitative measures 
of the LAA and left atrium (Table 2), but it is not expected to alter morphology 
description, being LAA morphology preserved through the different phases of the cardiac 
cycle. 
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Conclusion 
Age and LAA morphology relate to SCI burden in AF patients. If confirmed, LAA 
morphology would allow to refine thromboembolic risk prediction and treatment 
especially in patients with low CHA2DS2-VASc score.  
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Legend 
 
 Figure 1. Examples of the four progressively more complex left atrial appendage 
morphologies: Cactus (A), ChickenWing (B), WindSock (C), and Cauliflower (D). 
 
 Figure 2.  Axial FLAIR T2 images demonstrating a total of 33 silent ischemic 
lesions: 25 subcortical (8 in A, 7 in B, 10 in C, respectively), seven deep white matter (3 
in A, 4 in B, respectively) and one nucleus caudate (A) lesions. Clusters of lesions are 
indicated by arrows.  
 
 Figure 3. Quartile distribution of silent cerebral ischemia (SCI) by left atrium 
appendage (LAA) morphology (1st quartile, ≤ 6 SCI: white; 2nd quartile, 7-23 SCI: light 
grey; 3rd quartile, 24-43 SCI: dark grey; 4th quartile, ≥ 44 SCI: black; p=0.035).  
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Table 1. Baseline characteristics of the study population stratified by quartiles of 
silent cerebral ischemia (ANOVA p-value for continuous variables and Pearson's chi-
square or Fisher’s exact* p-value for categorical variables). 
 
OVERALL 
n=348 
≤ 6 SCI 
n=87 
7-23 SCI 
n=92 
24-43 SCI 
n=86 
≥ 44 SCI 
n=83 
p 
Gender (n, %)            
Male  274(78.7) 66(75.9) 76(82.6) 69(80.2) 63(75.9) 0.622 
Age (years) 57.4(±10.6) 52.5(±12.4) 56.7(±10.5) 58.0(±9.0) 62.8(±7.2) <0.001 
AF duration (months) 79.4(±71.2) 62.2(±56.7) 88.7(±90.4) 81.3(±65.9) 85.4(±63.8) 0.065 
Smoking habit (n,%) 72(20.7) 13(14.9) 20(21.7) 16(18.6) 23(27.7) 0.580 
Comorbidities (n,%)            
Hypertension 178(51.1) 36(41.4) 46(50.0) 47(54.7) 49(59.0) 0.119 
Diabetes 18(5.2) 6(6.9) 5(5.4) 4(4.7) 3(3.6) 0.832* 
Hypercholesterolemia 86(24.7) 15(17.2) 19(20.7) 25(29.1) 27(32.5) 0.071 
Underlying heart disease (n,%) 51(14.7) 19(21.8) 13(14.1) 11(12.8) 9(10.8) 0.809* 
coronary artery disease 25(7.2) 9(10.3) 4(4.3) 6(7.0) 6(7.2)  
Hypertrophic cardiomiopathy 8(2.3) 2(2.3) 3(3.3) 1(1.2) 2(2.4)  
Congenital heart disease 2(0.6) 1(1.1) 0(0) 1(1.2) 0(0)  
Hypocinetic cardiopathy 16(4.6) 6(6.9) 6(6.5) 3(3.5) 1(1.2)  
CHA2DS2-VASc (n,%)           0.240 
0-1 241(69.3) 63(72.4) 63(68.5) 63(73.3) 52(62.7)  
≥ 2 107(30.7) 24(27.6) 29(31.5) 23(26.7) 31(37.3)  
 
 
 
 
 
  23
 
Table 2. Left atrium and left atrial appendage parameters by echocardiography and 
magnetic resonance stratified by quartiles of silent cerebral ischemia. 
 
  
OVERALL 
n=348 
≤ 6 SCI 
n=87 
7-23 SCI 
n=92 
24-43 SCI 
n=86 
≥ 44 SCI 
n=83 
p 
TRANSTHORACIC ECHOCARDIOGRAPHIC DATA  
Ejection Fraction (%) 46.6(±7.8) 46.8(±6.6) 47.0(±8.6) 46.9(±7.5) 45.9(±8.4) 0.865 
A-P diameter (mm) 39.8(±15.9) 34.8(±15.7) 41.0(±15.9) 42.1(±16.6) 40.6(±15.0) 0.035 
S-I diameter (mm) 45.3(±6.2) 43.3(±5.6) 46.9(±6.2) 45.0(±6.0) 46.2(±6.5) 0.001 
M-L diameter (mm) 60.6(±7.8) 59.1(±7.5) 60.1(±8.4) 61.3(±7.8) 61.8(±7.2) 0.214 
TRANSESOPHAGEAL ECHOCARDIOGRAPHIC DATA 
 
LAA Peak Flow speed (cm/s) 61.4(±7.1) 61.1(±7.1) 61.3(±7.8) 62.1(±7.1) 61.0(±6.4) 0.737 
   Sinus Rhythm (60.9%) 63.0(±5.6) 62.6(±5.4) 63.1(±5.4) 64.3(±6.3) 62.1(±5.3) 0.310 
   Atrial Fibrillation  (39.1%) 58.8(±8.4) 58.2(±9.0) 58.4(±9.9) 59.7(±7.3) 58.8(±7.6) 0.883 
MRA/CT DATA 
LA volume (cm3) 89.2(±32.8) 83.8(±30.8) 87.0(±28.7) 95.8(±34.5) 91.6(±36.6) 0.119 
LAA volume (cm3) 8.0(±4.4) 8.5(±5.2) 7.7(±3.5) 8.0(±4.6) 8.0(±4.2) 0.784 
LAA ostium                       
Area (cm2) 5.3(±1.8) 5.1(±2.0) 5.5(±1.7) 5.4(±1.8) 5.3(±1.8) 0.474 
Perimeter (cm) 8.9(±1.6) 8.7(±1.7) 9.1(±1.3) 9.0(±1.8) 8.8(±1.7) 0.465 
Dmax (mm) 32.8(±6.5) 32.3(±6.7) 33.6(±5.6) 33.5(±7.3) 31.7(±6.12) 0.203 
dmin (mm) 20.1(±4.6) 19.1(±4.7) 20.7(±4.8) 20.0(±4.7) 20.5(±4.3) 0.120 
 
Dmax, maximum diameter; dmin, minimum diameter 
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Table 3. Multivariate analysis investigating the correlation between recorded clinical and 
echocardiographic parameters (unit for continuous variables reported in brackets), left 
atrial appendage morphology and number of silent cerebral ischemia (unit=10 lesions) 
expressed by regression coefficients (beta) and 95% confidence intervals (95%CI). For 
example, subjects with Cauliflower LAA (beta=0.605) present in mean 0.605*10 = 6.05 
lesions more than those presenting other LAA morphologies. 
 
 Beta 95% CI p 
Age (years) 0.124 0.084–0.163  <0.001 
AF duration (months) -0.005 (-0.011)–0.001 0.077 
Hypercholesterolemia 0.942 (-0.011)–1.895 0.053 
A-P diameter (mm) 0.45*10-4 (-0.025)–0.026 0.994 
S-I diameter (mm) -0.024 (-0.090)–0.042 0.471 
Cactus LAA -0.051 (-0.390)–0.289 0.770 
ChickenWing LAA -0.275 (-0.507)–(-0.043)  0.021 
WindSock LAA 0.384 0.116–0.652 0.005 
Cauliflower LAA 0.605 0.073–1.138 0.026 
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